Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rangering i aksjer #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Aksjekurs
$93.80
Sist synkronisert: 2025-04-28
Markedsverdi
$2.68B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Aerovate Therapeutics, Inc. (AVTE)

Kategori

Utbyttehistorikk for Aerovate Therapeutics, Inc. (AVTE)
Aerovate Therapeutics, Inc. (aksjesymbol: AVTE) har gitt totalt 1 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $2.40
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Aerovate Therapeutics, Inc. (AVTE) fra 2025 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
2026 (TTM) $2.40 0.00%
2025 $2.40 0.00%
Liste over alle utbyttebetalinger
År Utbytte Endre
2026 (TTM) $84.00 0.00%
2025 $84.00 0.00%
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH